Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1270

1.

The Neuroprotective Effect of Klotho is Mediated via Regulation of Members of the Redox System.

Zeldich E, Chen CD, Colvin TA, Bove-Fenderson EA, Liang J, Tucker Zhou TB, Harris DA, Abraham CR.

J Biol Chem. 2014 Jul 18. pii: jbc.M114.567321. [Epub ahead of print]

PMID:
25037225
[PubMed - as supplied by publisher]
Free Article
2.

Higher Glutamate + Glutamine and Reduction of N-acetylaspartate in Posterior Cingulate According to Age Range in Patients with Cognitive Impairment and/or Pain.

Fayed N, Andrés E, Viguera L, Modrego PJ, Garcia-Campayo J.

Acad Radiol. 2014 Jun 26. pii: S1076-6332(14)00153-6. doi: 10.1016/j.acra.2014.04.009. [Epub ahead of print] Review.

PMID:
24981958
[PubMed - as supplied by publisher]
3.

Characterization of Human Hippocampal Neural Stem/Progenitor Cells and Their Application to Physiologically Relevant Assays for Multiple Ionotropic Glutamate Receptors.

Fukushima K, Tabata Y, Imaizumi Y, Kohmura N, Sugawara M, Sawada K, Yamazaki K, Ito M.

J Biomol Screen. 2014 Jun 30. pii: 1087057114541149. [Epub ahead of print]

PMID:
24980597
[PubMed - as supplied by publisher]
4.

N-methyl-d-aspartate glutamate receptor (NMDA-R) antibodies in mild cognitive impairment and dementias.

Busse S, Brix B, Kunschmann R, Bogerts B, Stoecker W, Busse M.

Neurosci Res. 2014 Jun 25. pii: S0168-0102(14)00113-8. doi: 10.1016/j.neures.2014.06.002. [Epub ahead of print]

PMID:
24973618
[PubMed - as supplied by publisher]
5.

Memantine enhances recovery from stroke.

López-Valdés HE, Clarkson AN, Ao Y, Charles AC, Carmichael ST, Sofroniew MV, Brennan KC.

Stroke. 2014 Jul;45(7):2093-100. doi: 10.1161/STROKEAHA.113.004476. Epub 2014 Jun 17.

PMID:
24938836
[PubMed - in process]
6.

Dysregulation of TrkB Receptors and BDNF Function by Amyloid-β Peptide is Mediated by Calpain.

Jerónimo-Santos A, Vaz SH, Parreira S, Rapaz-Lérias S, Caetano AP, Buée-Scherrer V, Castrén E, Valente CA, Blum D, Sebastião AM, Diógenes MJ.

Cereb Cortex. 2014 May 23. pii: bhu105. [Epub ahead of print]

PMID:
24860020
[PubMed - as supplied by publisher]
7.

Previously Unrecognized Missense Mutation E126K of PSEN2 Segregates with Early Onset Alzheimer's Disease in a Family.

Müller U, Winter P, Bolender C, Nolte D.

J Alzheimers Dis. 2014 May 20. [Epub ahead of print]

PMID:
24844686
[PubMed - as supplied by publisher]
8.

Activation of neurotensin receptor 1 facilitates neuronal excitability and spatial learning and memory in the entorhinal cortex: beneficial actions in an Alzheimer's disease model.

Xiao Z, Cilz NI, Kurada L, Hu B, Yang C, Wada E, Combs CK, Porter JE, Lesage F, Lei S.

J Neurosci. 2014 May 14;34(20):7027-42. doi: 10.1523/JNEUROSCI.0408-14.2014.

PMID:
24828655
[PubMed - indexed for MEDLINE]
9.

α-Melanocyte stimulating hormone prevents GABAergic neuronal loss and improves cognitive function in Alzheimer's disease.

Ma K, McLaurin J.

J Neurosci. 2014 May 14;34(20):6736-45. doi: 10.1523/JNEUROSCI.5075-13.2014.

PMID:
24828629
[PubMed - indexed for MEDLINE]
10.

Region-Specific Expression of Tau, Amyloid-β Protein Precursor, and Synaptic Proteins at Physiological Condition or Under Endoplasmic Reticulum Stress in Rats.

Lin L, Yang SS, Chu J, Wang L, Ning LN, Zhang T, Jiang Q, Tian Q, Wang JZ.

J Alzheimers Dis. 2014 Apr 30. [Epub ahead of print]

PMID:
24787918
[PubMed - as supplied by publisher]
11.

Amyloid-β and proinflammatory cytokines utilize a prion protein-dependent pathway to activate NADPH oxidase and induce cofilin-actin rods in hippocampal neurons.

Walsh KP, Minamide LS, Kane SJ, Shaw AE, Brown DR, Pulford B, Zabel MD, Lambeth JD, Kuhn TB, Bamburg JR.

PLoS One. 2014 Apr 23;9(4):e95995. doi: 10.1371/journal.pone.0095995. eCollection 2014.

PMID:
24760020
[PubMed - in process]
Free PMC Article
12.

Altered arginine metabolism in Alzheimer's disease brains.

Liu P, Fleete MS, Jing Y, Collie ND, Curtis MA, Waldvogel HJ, Faull RL, Abraham WC, Zhang H.

Neurobiol Aging. 2014 Sep;35(9):1992-2003. doi: 10.1016/j.neurobiolaging.2014.03.013. Epub 2014 Mar 20.

PMID:
24746363
[PubMed - in process]
13.

Mint Proteins Are Required for Synaptic Activity-dependent Amyloid Precursor Protein (APP) Trafficking and Amyloid β Generation.

Sullivan SE, Dillon GM, Sullivan JM, Ho A.

J Biol Chem. 2014 May 30;289(22):15374-15383. Epub 2014 Apr 17.

PMID:
24742670
[PubMed - as supplied by publisher]
14.

PrP overdrive: Does inhibition of α-cleavage contribute to PrP<sup>C</sup> toxicity and prion disease?

McDonald AJ, Millhauser GL.

Prion. 2014 Apr 10;8(2). [Epub ahead of print] Review.

PMID:
24721836
[PubMed - as supplied by publisher]
15.

Tau phosphorylation and tau mislocalization mediate soluble Aβ oligomer-induced AMPA glutamate receptor signaling deficits.

Miller EC, Teravskis PJ, Dummer BW, Zhao X, Huganir RL, Liao D.

Eur J Neurosci. 2014 Apr;39(7):1214-24. doi: 10.1111/ejn.12507.

PMID:
24713000
[PubMed - in process]
16.

Design, synthesis and biological evaluation of small-azo-dyes as potent Vesicular Glutamate Transporters inhibitors.

Favre-Besse FC, Poirel O, Bersot T, Kim-Grellier E, Daumas S, El Mestikawy S, Acher FC, Pietrancosta N.

Eur J Med Chem. 2014 May 6;78:236-47. doi: 10.1016/j.ejmech.2014.03.056. Epub 2014 Mar 18.

PMID:
24686010
[PubMed - in process]
17.

Hippocampus-specific deficiency in RNA editing of GluA2 in Alzheimer's disease.

Gaisler-Salomon I, Kravitz E, Feiler Y, Safran M, Biegon A, Amariglio N, Rechavi G.

Neurobiol Aging. 2014 Aug;35(8):1785-91. doi: 10.1016/j.neurobiolaging.2014.02.018. Epub 2014 Mar 1.

PMID:
24679603
[PubMed - in process]
18.

Glutamatergic Dysfunctioning in Alzheimer's Disease and Related Therapeutic Targets.

Zádori D, Veres G, Szalárdy L, Klivényi P, Toldi J, Vécsei L.

J Alzheimers Dis. 2014 Mar 26. [Epub ahead of print]

PMID:
24670398
[PubMed - as supplied by publisher]
19.

Accumulation of oligomer-prone α-synuclein exacerbates synaptic and neuronal degeneration in vivo.

Rockenstein E, Nuber S, Overk CR, Ubhi K, Mante M, Patrick C, Adame A, Trejo-Morales M, Gerez J, Picotti P, Jensen PH, Campioni S, Riek R, Winkler J, Gage FH, Winner B, Masliah E.

Brain. 2014 May;137(Pt 5):1496-513. doi: 10.1093/brain/awu057. Epub 2014 Mar 24.

PMID:
24662516
[PubMed - indexed for MEDLINE]
20.

Alzheimer amyloid beta inhibition of Eg5/kinesin 5 reduces neurotrophin and/or transmitter receptor function.

Ari C, Borysov SI, Wu J, Padmanabhan J, Potter H.

Neurobiol Aging. 2014 Aug;35(8):1839-49. doi: 10.1016/j.neurobiolaging.2014.02.006. Epub 2014 Feb 10.

PMID:
24636920
[PubMed - in process]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk